According to a report by Lianhe Zaobao on January 24, the Health Sciences Authority (HSA) of Singapore, in collaboration with the Immigration and Checkpoints Authority (ICA) and the Singapore Police Force, dismantled an illegal e-cigarette distribution network earlier this month, seizing over 8,700 e-cigarettes.
During the period from January 5th to 7th, law enforcement authorities seized a large quantity of e-cigarettes and other regulated items. On January 6th, officials discovered 5500 e-cigarette components during an inspection at the Woodlands Checkpoint and arrested one man.
An investigation has revealed that the man intended to transport e-cigarette components to an industrial facility in Gagie Bahru. The next day, the Health Sciences Authority conducted a surprise raid on the facility and uncovered 3,200 e-cigarettes and related accessories, some of which contained etomidate. These products are suspected to have been sold through Telegram.
Currently, three individuals are under investigation for multiple laws including the Singapore Tobacco Advertising and Sales Control Act, the Poisons Act, the Customs Act, fraud, and the Misuse of Drugs Act.
According to the law, individuals who illegally sell e-cigarettes containing nicotine may face a maximum of two years in prison or a fine of 10,000 new dollars. Those who violate the Tobacco Advertising and Sales Control Act may be fined up to 10,000 new dollars or imprisoned for a maximum of 12 months, or both.
The Health Science Bureau stated that they will take strict enforcement actions against any illegal sales and use.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
